Forward Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Forward Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2022	Xanadu	$100.0M Series C	Margaret Wu	Bessemer Venture Partners, byFounders, Draper Associates, Plug & Play Ventures, World Fund, Jeffrey Lee, Tim Draper, Alumni Ventures, BDC Capital, Capricorn Investment Group, Pegasus Tech Ventures, Silicon Valley Bank
Oct 4, 2021	TO THE MARKET	$5.0M Series A	Carrie Colbert	Belle Michigan, Knightsgate Ventures, Spouting Rock Investments, Working Capital Fund
Aug 20, 2019	Virtuoso	$3.3M Seed	Krishna Visvanathan	Acequia Capital, Downing Ventures
Dec 4, 2018	Viracta Therapeutics	$10.0M Other Equity	Kevin Ye	Latterell Venture Partners, NantKwest, VI Ventures
Apr 6, 2017	Viracta Therapeutics	$18.4M Series B	Patrick Soon-Shiong	Latterell Venture Partners, Wicklow Capital
Aug 1, 2015	Syndax Pharmaceuticals	$80.0M Series C	Delos, Fidelity Management & Research Company	aMoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Arrowpoint Partners, BioMed Ventures, Cormorant Asset Management, EcoR1 Capital, Greenwood Capital, Jennison Associates, MPM Capital, OrbiMed, RusnanoMedInvest, Tavistock Group
Aug 1, 2013	Syndax Pharmaceuticals	$27.0M Series B	—	aMoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, MPM Capital, RusnanoMedInvest
Nov 6, 2012	Ambit Pharmaceuticals	$25.0M Other Equity	David Bonita	Aisling Capital, Apposite Capital, Gimv, GrowthWorks, MedImmune Ventures, Radius Ventures, Roche Ventures
Jun 10, 2011	Ambit Pharmaceuticals	$30.0M Series D	Allan Marchington	Genechem, Gimv, GrowthWorks, Horizon Technology Finance, MedImmune Ventures, NovaQuest Capital Management, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Aug 15, 2010	Syndax Pharmaceuticals	$6.0M Other Equity	—	Avalon Ventures, Domain Associates, MC Life Science Ventures, MPM Capital, Pappas Ventures
Jul 28, 2010	HemaQuest Pharmaceuticals	$4.0M Series B Extension	James Woody	Aberdare Ventures, De Novo Ventures, Lilly Ventures
Jun 23, 2010	Nereus Pharmaceuticals	$20.0M Other Equity	HBM Healthcare Investments	Advent International, Alta Partners, Astellas Venture Management, Gimv, Pacific Venture Group, Roche
Apr 21, 2010	HemaQuest Pharmaceuticals	$12.0M Series B	Naheed Ismaili Misfeldt	De Novo Ventures, Lilly Ventures
Feb 17, 2010	Tioga Pharmaceuticals	$18.0M Other Equity	—	BB Biotech Ventures, Genesys Capital, New Leaf Venture Partners
Nov 1, 2007	Ambit Biosciences	$49.0M Series D	—	OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, NovaQuest Capital Management, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Aug 9, 2007	Nereus Pharmaceuticals	$45.0M Series D	BankInvest Biomedical Venture	Advent International, Alta Partners, Astellas Venture Management, Boston Life Science Venture Corporation, Eminent II Venture Capital, Gimv, HBM Healthcare Investments, InterWest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund